Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - icodextrin, quantity: 75 g/l; sodium chloride, quantity: 5.4 g/l; sodium lactate, quantity: 4.5 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 51 mg/l - solution, dialysis - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - indicated as "an alternative osmotic agent in dialysis solution for the long dwell exchange in patients treated with peritoneal dialysis."

Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - sodium chloride, quantity: 5.38 g/l; calcium chloride dihydrate, quantity: 0.183 g/l; magnesium chloride hexahydrate, quantity: 0.0508 g/l; sodium lactate, quantity: 4.48 g/l; glucose monohydrate, quantity: 5.5 g/l - solution, irrigation - excipient ingredients: sodium hydroxide; water for injections - use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis.

Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - sodium chloride, quantity: 5.39 g/l; calcium chloride dihydrate, quantity: 0.183 g/l; magnesium chloride hexahydrate, quantity: 0.0508 g/l; sodium lactate, quantity: 4.48 g/l; glucose monohydrate, quantity: 5.5 g/l - solution, dialysis - excipient ingredients: sodium hydroxide; water for injections - indications: use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis.

Australia - English - Department of Health (Therapeutic Goods Administration)

vantive pty ltd - icodextrin, quantity: 75 g/l; sodium chloride, quantity: 5.4 g/l; sodium lactate, quantity: 4.5 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 51 mg/l - solution, dialysis - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - indicated as "an alternative osmotic agent in dialysis solution for the long dwell exchange in patients treated with peritoneal dialysis."

Israel - English - Ministry of Health

baxter healthcare distribution ltd., israel - calcium chloride; glucose; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - glucose 38.6 g/l; lactic acid as sodium 4.5 g/l; glucose as monohydrate 42.5 g/l; magnesium chloride 0.051 g/l; sodium chloride 5.4 g/l; calcium chloride 0.184 g/l - isotonic solutions - indicated whenever peritoneal dialysis is employed including acute and chronic renal failure, severe water retention, electrolyte disorders, drug intoxication.

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - icodextrin (unii: 2nx48z0a9g) (icodextrin - unii:2nx48z0a9g), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid - unii:33x04xa5at), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698) - icodextrin 7.5 g in 100 ml - extraneal (icodextrin) is indicated for a single daily exchange for the long (8- to 16- hour) dwell during continuous ambulatory peritoneal dialysis (capd) or automated peritoneal dialysis (apd) for the management of end-stage renal disease. extraneal is also indicated to improve (compared to 4.25% dextrose) long-dwell ultrafiltration and clearance of creatinine and urea nitrogen in patients with high average or greater transport characteristics, as defined using the peritoneal equilibration test (pet) [see clinical pharmacology (12), clinical studies (14)]. extraneal is contraindicated in patients with a known allergy to cornstarch or icodextrin. extraneal is contraindicated in patients with maltose or isomaltose intolerance and in patients with glycogen storage disease. extraneal is contraindicated in patients with severe lactic acidosis. extraneal contains lactate which may contribute to worsening acidosis if conversion to bicarbonate is impaired and may be associated with hyperventilation, lethargy, hypot

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose monohydrate, quantity: 25 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 183 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; water for injections - dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose monohydrate, quantity: 42.5 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 183 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; water for injections - dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose monohydrate, quantity: 15 g/l; sodium chloride, quantity: 5.38 g/l; sodium lactate, quantity: 4.48 g/l; calcium chloride dihydrate, quantity: 183 mg/l; magnesium chloride hexahydrate, quantity: 50.8 mg/l - solution, irrigation - excipient ingredients: hydrochloric acid; water for injections - dianeal low calcium peritoneal dialysis solution is indicated for use in chronic renal failure patients being maintained on continuous ambulatory peritoneal dialysis or intermittent peritoneal dialysis and/or automated peritoneal dialysis and can also be used for acute renal failure.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - calcium, quantity: 1.25 mmol/l; chloride, quantity: 102.5 mmol/l; sodium, quantity: 134 mmol/l; sodium chloride, quantity: 5.786 g/l; lactate, quantity: 35 mmol/l; sodium lactate, quantity: 3.925 g/l; glucose monohydrate, quantity: 16.5 g/l; calcium chloride dihydrate, quantity: 0.1838 g/l; magnesium, quantity: 0.5 mmol/l; magnesium chloride hexahydrate, quantity: 0.1017 g/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.